Polarean Imaging new CEO sets out new sales initiatives, extends cash runway | AIM:POLX, OTC:PLLWF
Polarean | LinkedIn
Triangle Inno - With FDA approval, Durham firm implements commercial strategy
Polarean Imaging Plc recibe el primer pedido de novo de un nuevo polarizador XENOVIEWtm -07 de diciembre 2023 a las 08:00 | MarketScreener
Polarean Imaging: A FTSE 100 Company in the Making? - YouTube
Polarean Imaging Plc Appoints Dr. Christopher von Jako as new CEO | Imaging Technology News
Polarean hits another key milestone with University of Missouri upgrade | AIM:POLX, OTC:PLLWF
Sistema de resonancia magnética de vanguardia incorpora imágenes de xenón hiperpolarizado para mejor evaluación de la ventilación pulmonar - RM - mobile.Medimaging.es
News and Press Releases | Polarean .com
Polarean Imaging plc Announces Positive Results From Pivotal Phase III Clinical Trials | Business Wire
Polarean | LinkedIn
Polarean Imaging Ltd Share Price (POLX) ORD GBP0.00037 | POLX
Polarean Xenon MRI Platform | Polarean .com
Polarean delivers key milestones in H1, extends cash runway to Q2 2024 - Vox Markets
Polarean joins forces with VIDA to accelerate adoption of advanced MRI technology - Vox Markets
Polarean Imaging plc | BioWorld
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G2WXGSOW2NIANG4CK7HK6T3RLI.jpg "Polarean Imaging says FDA rejects new drug application, shares slump | Reuters")
Polarean Imaging says FDA rejects new drug application, shares slump | Reuters
News and Press Releases | Polarean .com
Duke spinout Polarean exceeds expectations with lung-imaging trial, seeks meeting with FDA - Research Triangle Regional Partnership
Polarean (@PolareanImaging) / X
Polarean Xenon MRI Platform | Polarean .com
